-
1
-
-
0036734580
-
Rapid growth of retinoblastoma in a premature twin
-
Abramson D.H., et al. Rapid growth of retinoblastoma in a premature twin. Arch. Ophthalmol. 2002, 120(9):1232-1233.
-
(2002)
Arch. Ophthalmol.
, vol.120
, Issue.9
, pp. 1232-1233
-
-
Abramson, D.H.1
-
2
-
-
0029330813
-
The Gorlin syndrome gene: a tumor suppressor active in basal cell carcinogenesis and embryonic development
-
Bale A.E., Gailani M.R., Leffell D.J. The Gorlin syndrome gene: a tumor suppressor active in basal cell carcinogenesis and embryonic development. Proc. Assoc. Am. Physicians. 1995, 107(2):253-257.
-
(1995)
Proc. Assoc. Am. Physicians.
, vol.107
, Issue.2
, pp. 253-257
-
-
Bale, A.E.1
Gailani, M.R.2
Leffell, D.J.3
-
3
-
-
0031859038
-
Patching together the genetics of Gorlin syndrome
-
Bale S.J., Falk R.T., Rogers G.R. Patching together the genetics of Gorlin syndrome. J. Cutan. Med. Surg. 1998, 3(1):31-34.
-
(1998)
J. Cutan. Med. Surg.
, vol.3
, Issue.1
, pp. 31-34
-
-
Bale, S.J.1
Falk, R.T.2
Rogers, G.R.3
-
4
-
-
58349113391
-
Survival with retinoblastoma in the USA: 1975-2004
-
Broaddus E., Topham A., Singh A.D. Survival with retinoblastoma in the USA: 1975-2004. Br. J. Ophthalmol. 2009, 93(1):24-27.
-
(2009)
Br. J. Ophthalmol.
, vol.93
, Issue.1
, pp. 24-27
-
-
Broaddus, E.1
Topham, A.2
Singh, A.D.3
-
5
-
-
33750577666
-
Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome
-
Cajaiba M.M., Bale A.E., Alvarez-Franco M., McNamara J., Reyes-Mugica M. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome. Nat. Clin. Pract. Oncol. 2006, 3(10):575-580.
-
(2006)
Nat. Clin. Pract. Oncol.
, vol.3
, Issue.10
, pp. 575-580
-
-
Cajaiba, M.M.1
Bale, A.E.2
Alvarez-Franco, M.3
McNamara, J.4
Reyes-Mugica, M.5
-
6
-
-
70449728074
-
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program
-
Carol H., et al. Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program. Pediatr. Blood Cancer 2009, 53(7):1255-1263.
-
(2009)
Pediatr. Blood Cancer
, vol.53
, Issue.7
, pp. 1255-1263
-
-
Carol, H.1
-
7
-
-
77950470724
-
Initial testing of topotecan by the pediatric preclinical testing program
-
Carol H., et al. Initial testing of topotecan by the pediatric preclinical testing program. Pediatr. Blood Cancer 2010, 54(5):707-715.
-
(2010)
Pediatr. Blood Cancer
, vol.54
, Issue.5
, pp. 707-715
-
-
Carol, H.1
-
8
-
-
2942574955
-
Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma
-
Chen D., et al. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004, 5(6):539-551.
-
(2004)
Cancer Cell
, vol.5
, Issue.6
, pp. 539-551
-
-
Chen, D.1
-
9
-
-
0026760426
-
Requirement for a functional Rb-1 gene in murine development
-
Clarke A.R., et al. Requirement for a functional Rb-1 gene in murine development. Nature 1992, 359(6393):328-330.
-
(1992)
Nature
, vol.359
, Issue.6393
, pp. 328-330
-
-
Clarke, A.R.1
-
10
-
-
0033824472
-
Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer
-
DiCiommo D., Gallie B.L., Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin. Cancer Biol. 2000, 10(4):255-269.
-
(2000)
Semin. Cancer Biol.
, vol.10
, Issue.4
, pp. 255-269
-
-
DiCiommo, D.1
Gallie, B.L.2
Bremner, R.3
-
11
-
-
33745304849
-
Compensation by tumor suppressor genes during retinal development in mice and humans
-
Donovan S.L., Schweers B., Martins R., Johnson D., Dyer M.A. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol. 2006, 4:14.
-
(2006)
BMC Biol.
, vol.4
, pp. 14
-
-
Donovan, S.L.1
Schweers, B.2
Martins, R.3
Johnson, D.4
Dyer, M.A.5
-
12
-
-
2642541662
-
Mouse models of childhood cancer of the nervous system
-
Dyer M.A. Mouse models of childhood cancer of the nervous system. J. Clin. Pathol. 2004, 57(6):561-576.
-
(2004)
J. Clin. Pathol.
, vol.57
, Issue.6
, pp. 561-576
-
-
Dyer, M.A.1
-
13
-
-
0027756145
-
Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity
-
Echelard Y., et al. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 1993, 75(7):1417-1430.
-
(1993)
Cell
, vol.75
, Issue.7
, pp. 1417-1430
-
-
Echelard, Y.1
-
14
-
-
0026627965
-
Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9
-
Gailani M.R., et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992, 69(1):111-117.
-
(1992)
Cell
, vol.69
, Issue.1
, pp. 111-117
-
-
Gailani, M.R.1
-
15
-
-
69849094782
-
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program
-
Gorlick R., et al. Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program. Pediatr. Blood Cancer 2009, 53(4):594-598.
-
(2009)
Pediatr. Blood Cancer
, vol.53
, Issue.4
, pp. 594-598
-
-
Gorlick, R.1
-
16
-
-
0028946875
-
Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type
-
Gurney J.G., Severson R.K., Davis S., Robison L.L. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995, 75(8):2186-2195.
-
(1995)
Cancer
, vol.75
, Issue.8
, pp. 2186-2195
-
-
Gurney, J.G.1
Severson, R.K.2
Davis, S.3
Robison, L.L.4
-
17
-
-
15844382075
-
A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities
-
Hahn H., et al. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J. Biol. Chem. 1996, 271(21):12125-12128.
-
(1996)
J. Biol. Chem.
, vol.271
, Issue.21
, pp. 12125-12128
-
-
Hahn, H.1
-
18
-
-
77951747892
-
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program
-
Houghton P.J., et al. Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program. Pediatr. Blood Cancer 2000, 54(7):921-926.
-
(2000)
Pediatr. Blood Cancer
, vol.54
, Issue.7
, pp. 921-926
-
-
Houghton, P.J.1
-
19
-
-
73949122305
-
Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program
-
Houghton P.J., et al. Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program. Mol. Cancer Ther. 2010, 9(1):101-112.
-
(2010)
Mol. Cancer Ther.
, vol.9
, Issue.1
, pp. 101-112
-
-
Houghton, P.J.1
-
20
-
-
33750200389
-
Orchestrating ontogenesis: variations on a theme by sonic hedgehog
-
Ingham P.W., Placzek M. Orchestrating ontogenesis: variations on a theme by sonic hedgehog. Nat. Rev. Genet. 2006, 7(11):841-850.
-
(2006)
Nat. Rev. Genet.
, vol.7
, Issue.11
, pp. 841-850
-
-
Ingham, P.W.1
Placzek, M.2
-
21
-
-
0026702996
-
Effects of an Rb mutation in the mouse
-
Jacks T., et al. Effects of an Rb mutation in the mouse. Nature 1992, 359(6393):295-300.
-
(1992)
Nature
, vol.359
, Issue.6393
, pp. 295-300
-
-
Jacks, T.1
-
22
-
-
15844381336
-
Human homolog of patched, a candidate gene for the basal cell nevus syndrome
-
Johnson R.L., et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996, 272(5268):1668-1671.
-
(1996)
Science
, vol.272
, Issue.5268
, pp. 1668-1671
-
-
Johnson, R.L.1
-
23
-
-
0030598937
-
Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma
-
Kato M.V., et al. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma. Cancer Lett. 1996, 106(1):75-82.
-
(1996)
Cancer Lett.
, vol.106
, Issue.1
, pp. 75-82
-
-
Kato, M.V.1
-
24
-
-
67651205908
-
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program
-
Keshelava N., et al. Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program. Pediatr. Blood Cancer 2009, 53(3):505-508.
-
(2009)
Pediatr. Blood Cancer
, vol.53
, Issue.3
, pp. 505-508
-
-
Keshelava, N.1
-
25
-
-
70350227313
-
The insulin-like growth factor-1 receptor-targeting antibody, CP-751, 871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma
-
Kurmasheva R.T., et al. The insulin-like growth factor-1 receptor-targeting antibody, CP-751, 871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma. Cancer Res. 2009, 69(19):7662-7671.
-
(2009)
Cancer Res.
, vol.69
, Issue.19
, pp. 7662-7671
-
-
Kurmasheva, R.T.1
-
26
-
-
27144450572
-
Topotecan combination chemotherapy in two new rodent models of retinoblastoma
-
Laurie N.A., et al. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin. Cancer Res. 2005, 11(20):7569-7578.
-
(2005)
Clin. Cancer Res.
, vol.11
, Issue.20
, pp. 7569-7578
-
-
Laurie, N.A.1
-
27
-
-
33750590095
-
Inactivation of the p53 pathway in retinoblastoma
-
Laurie N.A., et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006, 444(7115):61-66.
-
(2006)
Nature
, vol.444
, Issue.7115
, pp. 61-66
-
-
Laurie, N.A.1
-
28
-
-
0026744563
-
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
-
Lee E.Y., et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359(6393):288-294.
-
(1992)
Nature
, vol.359
, Issue.6393
, pp. 288-294
-
-
Lee, E.Y.1
-
29
-
-
2942738996
-
The Hedgehog response network: sensors, switches, and routers
-
Lum L., Beachy P.A. The Hedgehog response network: sensors, switches, and routers. Science 2004, 304(5678):1755-1759.
-
(2004)
Science
, vol.304
, Issue.5678
, pp. 1755-1759
-
-
Lum, L.1
Beachy, P.A.2
-
30
-
-
2942512013
-
Cell type-specific effects of Rb deletion in the murine retina
-
MacPherson D., et al. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev. 2004, 18(14):1681-1694.
-
(2004)
Genes Dev.
, vol.18
, Issue.14
, pp. 1681-1694
-
-
MacPherson, D.1
-
31
-
-
77952703733
-
Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)
-
Maris J.M., et al. Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr. Blood Cancer 2010, 55:26-34.
-
(2010)
Pediatr. Blood Cancer
, vol.55
, pp. 26-34
-
-
Maris, J.M.1
-
32
-
-
0017349361
-
Characterization of a new continuous cell line derived from a human retinoblastoma
-
McFall R.C., Sery T.W., Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977, 37(4):1003-1010.
-
(1977)
Cancer Res.
, vol.37
, Issue.4
, pp. 1003-1010
-
-
McFall, R.C.1
Sery, T.W.2
Makadon, M.3
-
33
-
-
67651204923
-
Initial testing of aplidin by the pediatric pre-clinical testing program
-
Morton C.L., et al. Initial testing of aplidin by the pediatric pre-clinical testing program. Pediatr. Blood Cancer 2009, 53(3):509-512.
-
(2009)
Pediatr. Blood Cancer
, vol.53
, Issue.3
, pp. 509-512
-
-
Morton, C.L.1
-
34
-
-
0031044873
-
P53 regulates apoptosis in human retinoblastoma
-
Nork T.M., Poulsen G.L., Millecchia L.L., Jantz R.G., Nickells R.W. p53 regulates apoptosis in human retinoblastoma. Arch. Ophthalmol. 1997, 115(2):213-219.
-
(1997)
Arch. Ophthalmol.
, vol.115
, Issue.2
, pp. 213-219
-
-
Nork, T.M.1
Poulsen, G.L.2
Millecchia, L.L.3
Jantz, R.G.4
Nickells, R.W.5
-
35
-
-
51649115107
-
Retinoblastoma: one world, one vision
-
Rodriguez-Galindo C., et al. Retinoblastoma: one world, one vision. Pediatrics 2008, 122(3):e763-e770.
-
(2008)
Pediatrics
, vol.122
, Issue.3
-
-
Rodriguez-Galindo, C.1
-
36
-
-
67650289584
-
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
-
Scales S.J., de Sauvage F.J. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci. 2009, 30(6):303-312.
-
(2009)
Trends Pharmacol. Sci.
, vol.30
, Issue.6
, pp. 303-312
-
-
Scales, S.J.1
de Sauvage, F.J.2
-
37
-
-
14644397851
-
Diagnosis and management of retinoblastoma
-
Shields C.L., Shields J.A. Diagnosis and management of retinoblastoma. Cancer Control. 2004, 11(5):317-327.
-
(2004)
Cancer Control.
, vol.11
, Issue.5
, pp. 317-327
-
-
Shields, C.L.1
Shields, J.A.2
-
38
-
-
74849125377
-
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing program
-
Smith M.A., et al. Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing program. Pediatr. Blood Cancer 2010, 54(2):307-310.
-
(2010)
Pediatr. Blood Cancer
, vol.54
, Issue.2
, pp. 307-310
-
-
Smith, M.A.1
-
39
-
-
9744274770
-
The first knockout mouse model of retinoblastoma
-
Zhang J., Schweers B., Dyer M.A. The first knockout mouse model of retinoblastoma. Cell Cycle. 2004, 3(7):952-959.
-
(2004)
Cell Cycle.
, vol.3
, Issue.7
, pp. 952-959
-
-
Zhang, J.1
Schweers, B.2
Dyer, M.A.3
|